Skip to content

A Case Study on Cervical Nerve Neuromodulation in the Management of Speech and Cognitive Deficits after Central Nervous System Injury

A Case Study on Cervical Nerve Neuromodulation in the Management of Speech and Cognitive Deficits after Central Nervous System Injury

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112849
Enrollment
Unknown
Registered
2025-11-20
Start date
2025-11-24
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with cognitive impairment related to brain injury or cerebrovascular disease

Interventions

Intervention group:Neuromodulation, C7 nerve root resection

Sponsors

Jing'an District Central Hospital, Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 14-80 years, any gender; 2. Diagnosed by a neurologist with post-brain injury cognitive impairment or vascular cognitive impairment, meeting the clinical manifestations and imaging characteristics of post-brain injury cognitive impairment or vascular cognitive impairment; 3. MoCA-Basic score <24; 4. Onset time exceeding 6 months; 5. Has a stable caregiver available 24 hours a day; 6. Patient and caregiver have signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Presence of cognitive impairment caused by other non-cerebrovascular diseases or brain injuries, such as Alzheimer's disease, frontotemporal dementia, or Lewy body dementia; 2. Presence of other intracranial or extracranial lesions affecting cognitive function, such as brain tumors, severe hydrocephalus, or hypothyroidism; 3. Severe systemic diseases, such as malignant tumors, liver or kidney dysfunction, coagulopathy, or infectious diseases; 4. Patients and caregivers unable to cooperate with treatment; 5. Participation in other clinical interventional trials within the past 3 months.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment - Basic Score;Activities of Daily Living;Western Aphasia Battery;

Secondary

MeasureTime frame
Ancillary Tests (EEG, sEMG, MRI, PET, Facial Expression Analysis, Eye Tracking, and Gait Analysis);Movement Disorder Society - Unified Dystonia Rating Scale;Genomics, Proteomics;Zarit Burden Interview;Neuropsychiatric Inventory;Nonverbal Cognitive Scale;

Countries

China

Contacts

Public ContactWendong Xu

Jing'an District Central Hospital, Shanghai (Jing'an Branch of Huashan Hospital, Fudan University)

wendongxu@fudan.edu.cn+86 21 52888732

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026